Skip to content

Immediate Bonding and Caesarean Section

Effects of Immediate Bonding (Skin-to-skin Contact) During Caesarean Section- Psychobiological and Somatic Outcomes of Mother and Child

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02727452
Enrollment
30
Registered
2016-04-04
Start date
2016-03-31
Completion date
2019-12-31
Last updated
2022-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C-Section

Brief summary

The randomised study analyzes the effects of immediate bonding (skin-to-skin contact) on different psychobiological and somatic outcomes of mother and child. The investigators compare 3 bonding conditions. Cortisol and Oxytocin are also measured during the bonding process.

Interventions

Sponsors

Johann Wolfgang Goethe University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Mothers with elective Caesarean Section and their partners

Exclusion criteria

* premature birth * severe diseases * drug abuse

Design outcomes

Primary

MeasureTime frameDescription
Changes in Cortisol Level30 and 60 minutes after bondingCortisol is assessed as a stress parameter by Saliva. It will be tested in the mother and child to measure the effect of immediate bonding with the mother compared to the other 2 conditions on the stress level

Secondary

MeasureTime frameDescription
Mother-child-bonding1-3 days and 6 weeks after childbirthassessed by PBQ
Child's heart ratio30 and 60 minutes after birth
Depression1-3 days and 6 weeks after childbirthassessed by EPDS
Child's temperature30 and 60 minutes after birth
Oxytocin30 and 60 minutes after birthSaliva measurement
Child's oxygen saturation30 and 60 minutes after birth

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026